Corcept Therapeutics CORT Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's net change in cash?
- Corcept Therapeutics (CORT) reported net change in cash of -$11.76M in Q1 2026.
- How has Corcept Therapeutics's net change in cash changed year-over-year?
- Corcept Therapeutics's net change in cash increased by 68.9% year-over-year, from -$37.85M to -$11.76M.
- What does net change in cash mean?
- The total change in the company's cash balance over the period.
- How do you interpret net change in cash?
- A consistent increase indicates strong cash generation, while a decrease may signal heavy investment, debt repayment, or operational challenges.
- How does net change in cash compare across companies?
- A fundamental metric reported by all companies; used to assess overall financial health and liquidity trends.